Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
D000943:Antigens, Differentiation / Q000032:analysis; D001932:Brain Neoplasms / Q000628:therapy*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D004306:Dose-Response Relationship, Immunologic; D005910:Glioma / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000145:classification / Q000276:immunology*
D000943:Antigens, Differentiation; D007376:Interleukin-2